Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Fox

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Nature Reviews. Neurology|October 7, 2024
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosisLorraine V Kalia, Angelica Asis, Nathalie Arbour, et al.
JAMA Neurology|June 30, 2025
Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical TrialCarolina R A Silveira, Kristy K L Coleman, Kathy Borron, et al.
European Journal of Neurology|July 23, 2021
Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusionMeng Wang, Tolulope Sajobi, Francesca Morgante, et al.
Progress in Neurobiology|July 26, 2015
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's diseaseMatthieu F Bastide, Wassilios G Meissner, Barbara Picconi, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Nature Reviews. Neurology|October 7, 2024
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosisLorraine V Kalia, Angelica Asis, Nathalie Arbour, et al.
JAMA Neurology|June 30, 2025
Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical TrialCarolina R A Silveira, Kristy K L Coleman, Kathy Borron, et al.
European Journal of Neurology|July 23, 2021
Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusionMeng Wang, Tolulope Sajobi, Francesca Morgante, et al.
Progress in Neurobiology|July 26, 2015
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's diseaseMatthieu F Bastide, Wassilios G Meissner, Barbara Picconi, et al.
Pageof 8